Panel Discussion: Streamlining Biologics Scale-Up

Streamlining the transfer of an upstream bioprocess from research to production scale is critical for reducing development costs and time to market. In this panel discussion, Winston Wong (Eppendorf Americas), Klaus Ferber (Eppendorf AG), Ben Asher (Thermo Fisher Scientific) and John Shyu (Corning Life Sciences) discuss scale-up challenges from an economical, operational, and application-related point of view.